We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.56B
AUM Growth
+$200M
Cap. Flow
-$12.2M
Cap. Flow %
-0.48%
Top 10 Hldgs %
35.03%
Holding
185
New
38
Increased
44
Reduced
32
Closed
58

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$34.8M
2
AGN.PRA
Allergan plc
AGN.PRA
+$31.9M
3
EBAY icon
eBay
EBAY
+$28.5M
4
YUM icon
Yum! Brands
YUM
+$27.1M
5
HES
Hess
HES
+$22.8M

Top Sells

Rank Stock Value
1
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$29.6M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$23M
3
SNV
Synovus
SNV
+$21.7M
4
BLMN icon
Bloomin' Brands
BLMN
+$21.2M
5
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Consumer Discretionary 10.07%
3 Technology 9.69%
4 Consumer Staples 5.72%
5 Industrials 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWL icon
101
Newell Brands
NWL
$2.79B
$4.36M 0.17%
106,116
-182,238
-63% -$7.3M
ZVRA icon
102
Zevra Therapeutics
ZVRA
$590M
$4.13M 0.16%
+14,063
New +$3.07M
GEG icon
103
Great Elm Group
GEG
$70.6M
$4.05M 0.16%
545,021
– –
IVTY
104
DELISTED
Invuity, Inc
IVTY
$3.9M 0.15%
+276,000
New +$4.01M
AMPH icon
105
Amphastar Pharmaceuticals
AMPH
$886M
$3.63M 0.14%
206,539
-118,800
-37% -$1.85M
ATRS
106
DELISTED
Antares Pharma, Inc.
ATRS
$3.46M 0.14%
1,665,738
+500,000
+43% +$1.21M
AMSGP
107
DELISTED
Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1
AMSGP
$3.44M 0.13%
24,678
-15,322
-38% -$2.04M
MDCO
108
PUT
DELISTED
Medicines Co
MDCO
$2.86M 0.11%
100,000
-100,000
-50% -$2.79M
ALB icon
109
Albemarle
ALB
$14B
$2.76M 0.11%
+50,000
New +$2.98M
JAGX icon
110
Jaguar Health
JAGX
$4.96M
– –
0
– –
LPCN icon
111
Lipocine
LPCN
$17.2M
$2.57M 0.1%
+17,647
New +$2.19M
UHS icon
112
Universal Health Services
UHS
$10.3B
$2.57M 0.1%
+18,100
New +$2.27M
MESG
113
DELISTED
XURA INC COM (DE)
MESG
$2.56M 0.1%
+127,300
New +$2.92M
EAT icon
114
Brinker International
EAT
$9.54B
$2.34M 0.09%
40,515
-293,414
-88% -$16.8M
ADVM
115
CALL
DELISTED
Adverum Biotechnologies
ADVM
$2.27M 0.09%
14,000
+5,000
+56% +$1.69M
MDWD icon
116
MediWound
MDWD
$183M
$2.23M 0.09%
45,000
+4,120
+10% +$179K
CWEN icon
117
Clearway Energy Class C
CWEN
$4.98B
$2.19M 0.09%
+100,000
New +$2.52M
EEM icon
118
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$1.98M 0.08%
+50,000
New +$2.09M
NUVA
119
DELISTED
NuVasive, Inc.
NUVA
$1.92M 0.08%
+40,500
New +$1.89M
SGYP
120
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.66M 0.06%
+200,000
New +$969K
CIVI
121
DELISTED
Civitas Solutions, Inc.
CIVI
$1.58M 0.06%
74,050
– –
AAL icon
122
American Airlines Group
AAL
$10.6B
$608K 0.02%
450,000
– –
ACHC icon
123
Acadia Healthcare
ACHC
$2.84B
– –
-45,000
Closed -$3.22M
ADVM
124
DELISTED
Adverum Biotechnologies
ADVM
– –
-22,538
Closed -$7.6M
AIG icon
125
American International
AIG
$41.5B
– –
-115,000
Closed -$6.3M
3 4
5
6 7

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM

Kingdon Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Kingdon Capital Management held 185 positions worth $2.56B, up 8.5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kingdon Capital Management's Q2 2015 filing shows 38 new, 44 increased, 32 reduced and 58 closed positions. Its largest new stake was Allergan plc: 30,500 shares worth $31.9M. The largest sale was ANACOR PHARMACEUTICALS INC COM, an estimated $29.6M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Kingdon Capital Management's largest Q2 2015 buy was Allergan plc: 30,500 shares worth $31.9M.
  • Kingdon Capital Management added most to Adobe in Q2 2015, an estimated $34.8M increase.
  • Kingdon Capital Management's biggest Q2 2015 reduction was ANACOR PHARMACEUTICALS INC COM, cutting an estimated $29.6M.
  • Kingdon Capital Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $23M.
  • Kingdon Capital Management's ten largest holdings make up 35% of its $2.56B portfolio in Q2 2015.
  • Kingdon Capital Management opened 38 new positions and closed 58 in Q2 2015.
  • Kingdon Capital Management's portfolio value rose 8.5% quarter-over-quarter to $2.56B.

Based on Kingdon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.